A Recombinant Blood-Stage Malaria Vaccine Reduces Plasmodium falciparum Density and Exerts Selective Pressure on Parasite Populations in a Phase 1-2b … B Genton, I Betuela, I Felger, F Al-Yaman, RF Anders, A Saul, L Rare, ... The Journal of infectious diseases 185 (6), 820-827, 2002 | 588 | 2002 |
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum DJ Pombo, G Lawrence, C Hirunpetcharat, C Rzepczyk, M Bryden, ... The Lancet 360 (9333), 610-617, 2002 | 517 | 2002 |
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51 Y Wu, RD Ellis, D Shaffer, E Fontes, EM Malkin, S Mahanty, MP Fay, ... PloS one 3 (7), e2636, 2008 | 477 | 2008 |
Progress and challenges for malaria vaccines TL Richie, A Saul Nature 415 (6872), 694-701, 2002 | 463 | 2002 |
Mutations in Plasmodium falciparumCytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site M Korsinczky, N Chen, B Kotecka, A Saul, K Rieckmann, Q Cheng Antimicrobial agents and chemotherapy 44 (8), 2100-2108, 2000 | 452 | 2000 |
Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates U Wille-Reece, BJ Flynn, K Loré, RA Koup, AP Miles, A Saul, RM Kedl, ... The Journal of experimental medicine 203 (5), 1249-1258, 2006 | 351 | 2006 |
Discrimination of all Members of the Anopheles punctulatus Complex by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Analysis NW Beebe, A Saul The American journal of tropical medicine and hygiene 53 (5), 478-481, 1995 | 344 | 1995 |
stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens Q Cheng, N Cloonan, K Fischer, J Thompson, G Waine, M Lanzer, A Saul Molecular and biochemical parasitology 97 (1-2), 161-176, 1998 | 321 | 1998 |
In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a … MC Kennedy, J Wang, Y Zhang, AP Miles, F Chitsaz, A Saul, CA Long, ... Infection and immunity 70 (12), 6948-6960, 2002 | 302 | 2002 |
Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria EM Malkin, DJ Diemert, JH McArthur, JR Perreault, AP Miles, BK Giersing, ... Infection and immunity 73 (6), 3677-3685, 2005 | 297 | 2005 |
Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes GN Jakeman, A Saul, WL Hogarth, WE Collins Parasitology 119 (2), 127-133, 1999 | 295 | 1999 |
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria EM Malkin, AP Durbin, DJ Diemert, J Sattabongkot, Y Wu, K Miura, ... Vaccine 23 (24), 3131-3138, 2005 | 278 | 2005 |
Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin EP Rock, K Marsh, AJ Saul, TE Wellems, DW Taylor, WL Maloy, ... Parasitology 95 (2), 209-227, 1987 | 246 | 1987 |
Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria AW Stowers, MC Kennedy, BP Keegan, A Saul, CA Long, LH Miller Infection and immunity 70 (12), 6961-6967, 2002 | 236 | 2002 |
Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum JA Smythe, MG Peterson, RL Coppel, AJ Saul, DJ Kemp, RF Anders Molecular and Biochemical Parasitology 39 (2), 227-234, 1990 | 236 | 1990 |
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali I Sagara, A Dicko, RD Ellis, MP Fay, SI Diawara, MH Assadou, ... Vaccine 27 (23), 3090-3098, 2009 | 230 | 2009 |
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines K Miura, AC Orcutt, OV Muratova, LH Miller, A Saul, CA Long Vaccine 26 (2), 193-200, 2008 | 225 | 2008 |
Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species RA O'Donnell, A Saul, AF Cowman, BS Crabb Nature medicine 6 (1), 91-95, 2000 | 223 | 2000 |
Malaria transmission-blocking vaccines—how can their development be supported? R Carter, KN Mendis, LH Miller, L Molineaux, A Saul Nature medicine 6 (3), 241-244, 2000 | 202 | 2000 |
Update on the clinical development of candidate malaria vaccines WR Ballou, M Arevalo-Herrera, D Carucci, TL Richie, G Corradin, C Diggs, ... The Intolerable Burden of Malaria II: What's New, What's Needed: Supplement …, 2004 | 200 | 2004 |